Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.

Journal of cardiology - 1 May 2015

Terauchi Yasunobu, Kubo Toru, Baba Yuichi, Hirota Takayoshi, Tanioka Katsutoshi, Yamasaki Naohito, Furuno Takashi, Kitaoka Hiroaki

Abstract excerpt

BACKGROUND: Although gender may be one of the important factors modifying phenotypic expression in hypertrophic cardiomyopathy (HCM), there has been little information on it. METHODS AND RESULTS: We investigated gender differences in the clinical features of HCM caused by cardiac myosin-binding protein C gene (MYBPC3) mutations. Sixty-one subjects (28 families) carrying MYBPC3 mutations were studied. Of the 61...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carrier Proteins

Share to Heart Failure

Share to Incidence

Share to Kaplan-Meier Estimate

Share to Risk Factors

Share to Sex Factors

Source

Identifiers

PMID: 25123604
DOI: 10.1016/j.jjcc.2014.07.010

Genes

MYBPC3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.PMID 25123604Read ↗

Sex-Specific Clinical and Genetic Factors Associated with Adverse Outcomes in Hypertrophic CardiomyopathySemantic proximity Read ↗

Genetic Determinants of Clinical Phenotype in Hypertrophic CardiomyopathySemantic proximity Read ↗

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic CardiomyopathySemantic proximity Read ↗

Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3.Semantic proximity Read ↗

Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy.Semantic proximity Read ↗

Clinical Features and Prognostic Implications of Familial Hypertrophic Cardiomyopathy Related to the Cardiac Myosin-Binding Protein C GeneSemantic proximity Read ↗

A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Hypertrophic cardiomyopathy due to truncating variants in myosin binding protein C: a Spanish cohort.Semantic proximity Read ↗

A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.Semantic proximity Read ↗

Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.